SEC Form 4 · accession 0000950138-17-000047
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond J. Furey
Officer — Chief Compliance Officer
Period of report
Jan 4, 2017
Accepted (ET)
Jan 6, 2017 · 6:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jan 4, 2017 | F | 242 | $53.19 | D | 6,462 | D |
Table II — derivative securities
No Table II lines on this filing.